QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
NASDAQ:ELAB

Elevai Labs (ELAB) Stock Price, News & Analysis

$0.57
0.00 (-0.70%)
(As of 04:32 PM ET)
Today's Range
$0.57
$0.60
50-Day Range
$0.58
$0.80
52-Week Range
$0.57
$4.24
Volume
67,632 shs
Average Volume
1.30 million shs
Market Capitalization
$9.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ELAB stock logo

About Elevai Labs Stock (NASDAQ:ELAB)

Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.

ELAB Stock Price History

ELAB Stock News Headlines

Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
ELEVAI launches consumer skincare portal
FibroBiologics Announces Anticipated Listing Day
Why Is Elevai Labs (ELAB) Stock Up 57% Today?
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Why Is Elevai Labs (ELAB) Stock Up Today?
Elevai Labs Inc ELAB
Elevai Labs Inc (ELAB)
Elevai Labs Prices 1.5 Million-Share IPO at $4 a Share
Elevai Labs, Inc. Common Stock (ELAB)
See More Headlines
Receive ELAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevai Labs and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/29/2024
Today
4/16/2024
Next Earnings (Estimated)
7/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ELAB
Previous Symbol
NASDAQ:ELAB
Fax
N/A
Employees
16
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.71 million
Book Value
$0.22 per share

Miscellaneous

Free Float
N/A
Market Cap
$9.96 million
Optionable
N/A
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Jordan R. Plews Ph.D. (Age 41)
    Co-Founder, President, CEO & Director
    Comp: $210k
  • Ms. Brenda Buechler (Age 54)
    Chief Marketing Officer
    Comp: $195k
  • Mr. Christoph Kraneiss (Age 53)
    Chief Commercial Officer
    Comp: $188.55k
  • Dr. Hatem Abou-Sayed F.A.C.S. (Age 53)
    FACS, M.B.A., M.D., MBA, Co-Founder, Chief Medical Officer & Director
  • Mr. Graydon Bensler C.F.A. (Age 33)
    CFO, Secretary & Director

ELAB Stock Analysis - Frequently Asked Questions

How have ELAB shares performed in 2024?

Elevai Labs' stock was trading at $1.8282 at the start of the year. Since then, ELAB stock has decreased by 68.5% and is now trading at $0.5757.
View the best growth stocks for 2024 here
.

Are investors shorting Elevai Labs?

Elevai Labs saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 33,000 shares, a drop of 34.7% from the March 15th total of 50,500 shares. Based on an average daily trading volume, of 1,460,000 shares, the days-to-cover ratio is currently 0.0 days.
View Elevai Labs' Short Interest
.

When is Elevai Labs' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, July 5th 2024.
View our ELAB earnings forecast
.

How were Elevai Labs' earnings last quarter?

Elevai Labs, Inc. (NASDAQ:ELAB) announced its quarterly earnings data on Friday, March, 29th. The company reported ($0.08) earnings per share (EPS) for the quarter. The company had revenue of $0.70 million for the quarter.

When did Elevai Labs IPO?

Elevai Labs (ELAB) raised $6 million in an initial public offering (IPO) on Tuesday, November 21st 2023. The company issued 1,500,000 shares at a price of $4.00 per share. Univest Securities served as the underwriter for the IPO.

When does Elevai Labs' lock-up period expire?

Elevai Labs' lock-up period expires on Monday, May 20th. Elevai Labs had issued 1,500,000 shares in its public offering on November 21st. The total size of the offering was $6,000,000 based on an initial share price of $4.00. After the end of Elevai Labs' lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

How do I buy shares of Elevai Labs?

Shares of ELAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ELAB) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners